| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Ops & Quality
1 company
Andrew L Lux last filed a Form 4 in June 2017, as SVP, Ops & Quality at ATRC. Andrew L Lux's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 66,549 shares of ATRC. The ATRC filings lean toward selling, a net 25,038 shares.
Andrew L Lux has 15 Form 4 filings on record from January 2015 to June 2017, all as SVP, Ops & Quality at AtriCure (ATRC), 2015–2017.
The 19 reported transactions were 9 tax withholdings, 7 stock awards, 2 open-market sales and 1 option exercise.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $472K.
The largest open-market sale was 20,000 shares of ATRC at an average $18.85 on March 17, 2017, about $377K.
Shares as reported in the last Form 4 for each company; the most recent is from June 2017. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.